US-Listed Pharmaceutical Preparations — Net Income Percentiles, FY 2022
Population: 634 US-listed companies (SIC 2834), fiscal year 2022; fiscal year ends 2022-06-30 to 2023-05-31.
Cite as: FACTANKER, https://factanker.com/industries/sic-2834/net-income/2022
Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest
| 10th percentile | $-184.8M |
|---|---|
| 25th percentile | $-89.1M |
| Median | $-35.2M |
| 75th percentile | $-8.8M |
| 90th percentile | $3.0M |
| Mean | $92.4M |
| Minimum | $-2.9B |
| Maximum | $31.4B |
Methodology & sources
Net Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2022 = fiscal years ending 2022-06-01 to 2023-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-07.
Net Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2022 = fiscal years ending 2022-06-01 to 2023-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-07.
Evidence samples
Latest Net Income percentiles (live) · All Pharmaceutical Preparations benchmarks · All industries